Press Releases
Feb 24, 2020
Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Feb 24, 2020
Twist Bioscience Launches New NGS Solutions, Highlights Customers at 2020 Advances in Genome Biology and Technology Conference
Feb 24, 2020
GenapSys Partners With Twist Bioscience to Bring Next-Generation Sequencing Target Enrichment and Library Preparation to World’s Most Accessible Highly Accurate Sequencer
Feb 19, 2020
Twist Bioscience Announces Pricing of Upsized $130.0 Million Public Offering of Common Stock
Feb 18, 2020
Twist Bioscience Announces Proposed Public Offering of Common Stock
Feb 12, 2020
Twist Bioscience Now ISO 27001:2013 Certified for Information Security Management System
Feb 06, 2020
Twist Bioscience Reports First Quarter Fiscal 2020 Financial Results
Feb 06, 2020
Twist Bioscience Announces Settlement Agreement with Agilent
Jan 31, 2020
CORRECTING and REPLACING Twist Bioscience Announces Completion of $50 Million Offering Priced At-The-Market
Jan 27, 2020
Twist Bioscience Announces Completion of $50 Million Registered Direct Offering Priced At-The-Market